Abstract
Despite the introduction of direct-acting antivirals which simplified treatment and significantly increased cure rates, hepatitis C virus (HCV) treatment barriers persist. The number of HCV specialists is limited, particularly in rural and medically underserved areas, and patients often do not have access to care and treatment. Project ECHO was developed to increase the number of patients optimally treated for HCV through their local primary care clinics. Since its inception, the ECHO model has been used to improve HCV access across the USA and globally. Project ECHO and the ECHO model represent a revolutionary approach to expanding access to treatment for HCV.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
